biolitec turnover jumps, but falls short of predictions
This article was originally published in Clinica
Germany company biolitec last month recorded a rise in turnover of 78% compared with the previous year. The company, which develops and produces light-activated drugs for photodynamic therapy (PDT), diode lasers and laser delivery systems, increased turnover to DM36.2 million ($17 million) in the fiscal year ending June 30. biolitec's net income rose to DM3.6 million, an increase of 152%. The company concedes that, despite what it describes as a highly successful year, it still did not make its expected sales target of DM38.3 million.